Affiliations
AffiliationItem in Clipboard
Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future ratesBrenda K Edwards et al. Cancer. 2010.
. 2010 Feb 1;116(3):544-73. doi: 10.1002/cncr.24760. Authors Brenda K Edwards 1 , Elizabeth Ward, Betsy A Kohler, Christie Eheman, Ann G Zauber, Robert N Anderson, Ahmedin Jemal, Maria J Schymura, Iris Lansdorp-Vogelaar, Laura C Seeff, Marjolein van Ballegooijen, S Luuk Goede, Lynn A G Ries AffiliationItem in Clipboard
AbstractBackground: The American Cancer Society, the Centers for Disease Control and Prevention (CDC), the National Cancer Institute (NCI), and the North American Association of Central Cancer Registries (NAACCR) collaborate annually to provide updated information regarding cancer occurrence and trends in the United States. This year's report includes trends in colorectal cancer (CRC) incidence and death rates and highlights the use of microsimulation modeling as a tool for interpreting past trends and projecting future trends to assist in cancer control planning and policy decisions.
Methods: Information regarding invasive cancers was obtained from the NCI, CDC, and NAACCR; and information on deaths was obtained from the CDC's National Center for Health Statistics. Annual percentage changes in the age-standardized incidence and death rates (based on the year 2000 US population standard) for all cancers combined and for the top 15 cancers were estimated by joinpoint analysis of long-term trends (1975-2006) and for short-term fixed-interval trends (1997-2006). All statistical tests were 2-sided.
Results: Both incidence and death rates from all cancers combined significantly declined (P < .05) in the most recent time period for men and women overall and for most racial and ethnic populations. These decreases were driven largely by declines in both incidence and death rates for the 3 most common cancers in men (ie, lung and prostate cancers and CRC) and for 2 of the 3 leading cancers in women (ie, breast cancer and CRC). The long-term trends for lung cancer mortality in women had smaller and smaller increases until 2003, when there was a change to a nonsignificant decline. Microsimulation modeling demonstrates that declines in CRC death rates are consistent with a relatively large contribution from screening and with a smaller but demonstrable impact of risk factor reductions and improved treatments. These declines are projected to continue if risk factor modification, screening, and treatment remain at current rates, but they could be accelerated further with favorable trends in risk factors and higher utilization of screening and optimal treatment.
Conclusions: Although the decrease in overall cancer incidence and death rates is encouraging, rising incidence and mortality for some cancers are of concern.
Copyright 2009 American Cancer Society.
FiguresFigure 1
Natural History and Interventions on…
Figure 1
Natural History and Interventions on colorectal Cancer
Figure 1Natural History and Interventions on colorectal Cancer
Figure 2
Figure 2A. Colorectal Cancer Age-Standardized…
Figure 2
Figure 2A. Colorectal Cancer Age-Standardized Incidence Rates by Stage at Diagnosis SEER 9…
Figure 2Figure 2A. Colorectal Cancer Age-Standardized Incidence Rates by Stage at Diagnosis SEER 9 Incidence, 1975–2006, All Races, Both Sexes Figure 2B. Colorectal Cancer 5-year Relative Survival Rates by Stage at Diagnosis SEER 9 Incidence, 1975–2001, All Races, Both Sexes Source: SEER 9 areas (San Francisco, connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah and Atlanta). Incidence rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103). Regression lines with up to 4 Joinpoints are calculated using the Joinpoint Regression Program Version 3.3.1, April 2008, National Cancer Institute. Stage analyses were based on SEER historic stage categories using extent of Disease codes and the Collaborative Stage Data Collection system. Relative survival was calculated with the SEER*stat software ( www.seer.cancer.gov/seerstat ) version 6.5.2: NCI; 2009.
Figure 3
Partition of Past Trends in…
Figure 3
Partition of Past Trends in Colorectal Cancer Incidence* (1975–2000) * Rates are based…
Figure 3Partition of Past Trends in Colorectal Cancer Incidence* (1975–2000) * Rates are based on the first primary colorectal cancer and include the primary sites of C18.0 C18.2–C18.9, C19.9, C20.9 and the ICD-03 histologies of: 8000–8001, 8010, 8020, 8140, 8210–8211. Rates do not include cases that are form a reporting source of death certificate only or autopsy only.
Figure 4
Partition of Past Trends in…
Figure 4
Partition of Past Trends in Colorectal Cancer Mortality (1975–2000) Source: CDC National Center…
Figure 4Partition of Past Trends in Colorectal Cancer Mortality (1975–2000) Source: CDC National Center for Health Statistics (NCHS) National Vital Statistics System. Heron M, Hoyert DL, Murphy SL, Xu J, Kochanek KD, Tejada-Vera B. Deaths: Final data for 2006. National Vital Statistics Reports, Apr 17, 2009; 57(14).
Figure 5
Projections of Colorectal Cancer Mortality…
Figure 5
Projections of Colorectal Cancer Mortality with Differing Intensities of Cancer Control (2000–2020) Source:…
Figure 5Projections of Colorectal Cancer Mortality with Differing Intensities of Cancer Control (2000–2020) Source: CDC National Center for Health Statistics (NCHS) National Vital Statistics System. Heron M, Hoyert DL, Murphy SL, Xu J, Kochanek KD, Tejada-Vera B. Deaths: Final data for 2006. National Vital Statistics Reports, Apr 17, 2009; 57(14).
Figure 6
Contributions of Risk Factors, Screening…
Figure 6
Contributions of Risk Factors, Screening and Treatment to Optimistic Projections of Colorectal Cancer…
Figure 6Contributions of Risk Factors, Screening and Treatment to Optimistic Projections of Colorectal Cancer Mortality (2000 – 2020) Source: CDC National Center for Health Statistics (NCHS) National Vital Statistics System. Heron M, Hoyert DL, Murphy SL, Xu J, Kochanek KD, Tejada-Vera B. Deaths: Final data for 2006. National Vital Statistics Reports, Apr 17, 2009; 57(14).
Similar articlesJemal A, Thun MJ, Ries LA, Howe HL, Weir HK, Center MM, Ward E, Wu XC, Eheman C, Anderson R, Ajani UA, Kohler B, Edwards BK. Jemal A, et al. J Natl Cancer Inst. 2008 Dec 3;100(23):1672-94. doi: 10.1093/jnci/djn389. Epub 2008 Nov 25. J Natl Cancer Inst. 2008. PMID: 19033571 Free PMC article.
Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LA, Schrag D, Jamison PM, Jemal A, Wu XC, Friedman C, Harlan L, Warren J, Anderson RN, Pickle LW. Edwards BK, et al. J Natl Cancer Inst. 2005 Oct 5;97(19):1407-27. doi: 10.1093/jnci/dji289. J Natl Cancer Inst. 2005. PMID: 16204691
Weir HK, Thun MJ, Hankey BF, Ries LA, Howe HL, Wingo PA, Jemal A, Ward E, Anderson RN, Edwards BK. Weir HK, et al. J Natl Cancer Inst. 2003 Sep 3;95(17):1276-99. doi: 10.1093/jnci/djg040. J Natl Cancer Inst. 2003. PMID: 12953083 Review.
Kohler BA, Ward E, McCarthy BJ, Schymura MJ, Ries LA, Eheman C, Jemal A, Anderson RN, Ajani UA, Edwards BK. Kohler BA, et al. J Natl Cancer Inst. 2011 May 4;103(9):714-36. doi: 10.1093/jnci/djr077. Epub 2011 Mar 31. J Natl Cancer Inst. 2011. PMID: 21454908 Free PMC article.
Simard EP, Ward EM, Siegel R, Jemal A. Simard EP, et al. CA Cancer J Clin. 2012 Mar-Apr;62(2):118-28. doi: 10.3322/caac.20141. Epub 2012 Jan 4. CA Cancer J Clin. 2012. PMID: 22281605 Review.
Liu D, Yu X, Wang S, Dai E, Jiang L, Wang J, Yang Q, Yang F, Zhou S, Jiang W. Liu D, et al. Oncotarget. 2016 Aug 30;7(35):57228-57238. doi: 10.18632/oncotarget.11128. Oncotarget. 2016. PMID: 27528026 Free PMC article.
Scarinci IC, Litton AG, Garcés-Palacio IC, Partridge EE, Castle PE. Scarinci IC, et al. Womens Health Issues. 2013 Mar-Apr;23(2):e123-30. doi: 10.1016/j.whi.2012.12.003. Epub 2013 Feb 12. Womens Health Issues. 2013. PMID: 23410619 Free PMC article.
Moriasi C, Subramaniam D, Awasthi S, Ramalingam S, Anant S. Moriasi C, et al. Anticancer Agents Med Chem. 2012 Dec;12(10):1221-38. doi: 10.2174/187152012803833080. Anticancer Agents Med Chem. 2012. PMID: 22583410 Free PMC article. Review.
Nedaeinia R, Sharifi M, Avan A, Kazemi M, Rafiee L, Ghayour-Mobarhan M, Salehi R. Nedaeinia R, et al. Cancer Gene Ther. 2016 Aug;23(8):246-53. doi: 10.1038/cgt.2016.25. Epub 2016 Jul 1. Cancer Gene Ther. 2016. PMID: 27364574
Zhou P, Sun L, Liu D, Liu C, Sun L. Zhou P, et al. Pathol Oncol Res. 2016 Oct;22(4):733-40. doi: 10.1007/s12253-016-0061-x. Epub 2016 Apr 12. Pathol Oncol Res. 2016. PMID: 27071407
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3